Optimal Therapeutic Window for Steroid Use in Severe Alcohol-Associated Hepatitis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Identification of optimal therapeutic window for steroid use in severe alcohol-associated hepatitis: A worldwide study
J. Hepatol. 2021 Nov 01;75(5)1026-1033, JP Arab, LA Díaz, N Baeza, F Idalsoaga, E Fuentes-López, J Arnold, CA Ramírez, D Morales-Arraez, M Ventura-Cots, E Alvarado-Tapias, W Zhang, V Clark, D Simonetto, JC Ahn, S Buryska, TI Mehta, H Stefanescu, A Horhat, A Bumbu, W Dunn, B Attar, R Agrawal, ZS Haque, M Majeed, J Cabezas, I García-Carrera, R Parker, B Cuyàs, M Poca, G Soriano, SK Sarin, R Maiwall, PK Jalal, S Abdulsada, MF Higuera-de la Tijera, AV Kulkarni, PN Rao, P Guerra Salazar, L Skladaný, N Bystrianska, V Prado, A Clemente-Sanchez, D Rincón, T Haider, KR Chacko, F Cairo, M de Sousa Coelho, GA Romero, FD Pollarsky, JC Restrepo, S Castro-Sanchez, LG Toro, P Yaquich, M Mendizabal, ML Garrido, A Narvaez, F Bessone, JS Marcelo, D Piombino, M Dirchwolf, JP Arancibia, J Altamirano, W Kim, RC Araujo, AD Rojo, V Vargas, PE Rautou, T Issoufaly, F Zamarripa, A Torre, MR Lucey, P Mathurin, A Louvet, G García-Tsao, JA González, E Verna, RS Brown, JP Roblero, JG Abraldes, M Arrese, VH Shah, PS Kamath, AK Singal, R BatallerFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.